Pneumococcal and Meningococcal Diseases Completed Phase 3 Trials for Bordetella pertussis pertactin antigen (formaldehyde inactivated) (DB10992)

IndicationStatusPhase
DBCOND0037724 (Pneumococcal and Meningococcal Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs